LAB FY 2018 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$113M+10.8% YoY

Gross Profit

$62M54.6% margin

Operating Income

-$48M-42.6% margin

Net Income

-$59M-52.2% margin

EPS (Diluted)

$-1.49

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$304M

Total Liabilities

$232M

Stockholders' Equity

$72M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$113M	$102M	+10.8%
Gross Profit	$62M	$52M	+18.6%
Operating Income	-$48M	-$58M	+17.5%
Net Income	-$59M	-$61M	+2.5%